Clinical biospecimens: Reference materials, certified for nominal properties?

Biopreservation and Biobanking

Volumn 12, Issue 2, 2014, Pages 113-120

  Betsou, Fay ^a  

^a INTEGRATED BIOBANK OF LUXEMBOURG   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ACUTE CHLAMYDIA TRACHOMATIS INFECTION; ANATOMICAL CONCEPTS; ARTICLE; ASSAY; CANCER CELL CULTURE; CELL LINE; CEREBROSPINAL FLUID; CERTIFICATION; CHLAMYDIASIS; CLINICAL BIOSPECIMEN; CYTOLOGY; DIAGNOSTIC TEST; DNA METHYLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; INFORMATION PROCESSING; LUNG ADENOCARCINOMA; MEDICAL DOCUMENTATION; METABOLOMICS; MICROBIOLOGY; MOLECULAR BIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEOMICS; QUALITY CONTROL; QUANTITATIVE ASSAY; SERUM; TISSUES; URINE; BLOOD; BLOOD SAMPLING; FROZEN SECTION; GENETICS; HEALTH CARE FACILITY; ISOLATION AND PURIFICATION; LUNG TUMOR; METABOLISM; PATHOLOGY; STANDARD; STANDARDS; TUMOR CELL LINE;

BIOLOGICAL SPECIMEN BANKS; BLOOD SPECIMEN COLLECTION; CELL LINE, TUMOR; CHLAMYDIA INFECTIONS; DNA; FROZEN SECTIONS; HUMANS; LUNG NEOPLASMS; PARKINSON DISEASE; QUALITY CONTROL; REFERENCE STANDARDS;

EID: 84899089234     PISSN: 19475535     EISSN: 19475543     Source Type: Journal    
DOI: 10.1089/bio.2013.0086     Document Type: Article

References (35)

1. European Medicine Agency. Reflection paper on codevelopment of pharmacogenomic biomarkers and assays in the context of drug development. EMA/CHMP/641298/2008.
2. European Parliament. Proposal for a Regulation of the European Parliament and of the Council on in vitro diagnostic medical devices. COM 2012/0267.
3. Betsou F, Lehmann S, Ashton G, et al. Standard preanalytical coding for biospecimens: Defining the sample PREanalytical Code (SPREC). Cancer Epidemiol Biomarkers Prev 2010;19:1004-1011.
4. Moore HM, Kelly A, Jewell SD, et al. Biospecimen reporting for improved study quality. Biopreserv Biobank 2011;9:57-70.
5. Lehmann S, Guadagni F, Moore H, et al. Standard preanalytical coding for biospecimens: Review and implementation of the Sample PREanalytical Code (SPREC). Biopreserv Biobank 2012;10:366-374.
6. Diamandis EP. Cancer biomarkers: Can we turn recent failures into successes? J Natl Cancer Inst 2010;102:1462-1467.
7. ISO General requirements for the competence of reference materials producers, International Organization for Standardization, Geneva, Switzerland, ISO Guide 34:2009.
8. Nordin G, Dybkaer R, Forsum U, Fuentes-Arderiu X, Schadow G, Pontet F. An outline for a vocabulary of nominal properties and examinations-Basic and general concepts and associated terms. Clin Chem Lab Med 2010;48:1553-1566.
9. Teunissen CE, Petzold A, Bennett JL, et al. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology 2009;73:1914-1922.
10. Radouani F, Maille J, Betsou F. Serological profiling with Chlamycheck, a commercial multiplex recombinant antigen Western blot assay of chlamydial infections. Can J Microbiol 2007;53:1360-1368. (Pubitemid 351229371)
11. Dirks WG, Frexler HG. Authentication of scientific human cell lines: Easy-to-use DNA fingerprinting. Methods Mol Biol 2005;290:35-50.
12. Hay RJ. Cell Quantitation and characterization. In: Methods of Tissue Engineering, Atala A, Lanza RP (eds), Academic Press, San Diego: pp. 55-84, 2002.
13. European Pharmacopoeia 2007; 5.8-2.6.7.
14. Chernesky MA. The laboratory diagnosis of Chlamydia trachomatis infections. Can J Infect Dis Med Microbiol 2005;16:15-25.
15. Reid Y, Mintzer J. The current state of cell contamination and authentication-and what it means to biobanks. Biopreserv Biobank. 2012;10:236-238.
16. WHO Classification of Tumours. Tumours of the lung, pleura, thymus and heart. IARC Press 2004.
17. UICC, International Union Against Cancer (UICC): TNM Classification of Malignant Tumours. 6th ed. Wiley and Sons: New York, 2002.
18. Rami-Porta R, Crowley JJ, Goldstraw P. The revised classification TNM staging system for lung cancer. Ann Thorac Cardiovasc Surg 2009;15:4-9.
19. Mitelman F, Johansson B, Mertens F. Mitelman database of chromosome aberrations in cancer, 2003 http://cgap.nci .nih.gov/chromosomes/mitelman. Accessed 26 March 2014.
20. Kofanova O, Betsou F. DNA fingerprinting: A quality control case study for human biospecimen authentication. Biopreserv Biobank. 2014;17:151-153.
21. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease. A clinico-pathological study of 100 cases. JNNP 1992;55: 181-184.
22. Berg D, Lang AE, Postuma RB, Maetzler W, Deuschl G, Gasser T, Siderowf A. Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities. Lancet Neurol 2013;12:514-524.
23. Goetz GC, Tilley BC, Shaftman SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Movement Dis 2008;23:2129-2170.
24. Reiber H, Peter JB. Cerebrospinal fluid analysis-Disease related data patterns and evaluation programs. J Neurol Sci 2001;184:101-122. (Pubitemid 32178265)
25. Reiber H, Otto M, Trendelenburg C, Wormek A. Reporting cerebrospinal fluid data-Kknowledhe base and interpretation software. Clin Chem Lab Med 2001;39: 324-332. (Pubitemid 32433333)
26. Parnetti L, Castrioto A, Chiasserini D, Persichetti E, Tambasco N, El-Agnaf O, Calabresi P. Cerebrospinal fluid biomarkers in Parkinson disease. Nature Rev Neurol 2013; 9:131-140.
27. Romano P, Manniello A, Aresu O, Armento M, Cesaro M, Parodi B. Cell line Data Base: Structure and recent improvements towards molecular authentication of human cell lines. Nucleic Acids Res 2009;37:D925-D932.
28. Freshney RI. Cell line provenance. Cytotechnology 2002; 39:55-67. (Pubitemid 36560299)
29. Lengellea J, Panopoulos E, Betsou F. Soluble CD40-Ligand as a biomarker for storage-related preanalytic variations of human serum. Cytokine 2008;44:275-282.
30. van Beers EH, Joosse SA, Ligtenberg MJ, Fles R, Hogervorst FBL, Verhoef S, Nederlof PM. A multiplex PCR predictor for aCGH success of FFPE samples. Br J Cancer 2006;94:333-337. (Pubitemid 43151556)
31. Nolan T, Hands RE, Ogunkolade W, Bustin SA. SPUD: A quantitative PCR assay for the detection of inhibitors in nucleic acid preparations. Anal Biochem 2006;351: 308-310.
32. Deer EL, Gonzalez-Hernandez J, Coursen JD, et al. Phenotype and genotype of pancreatic cancer cell lines. Pancreas 2010;39:425-435.
33. Van Iwaarden P, Meeus N, Corbisier P. Certification of a Reference Material of purified genomic DNA from Campylobacter jejuni (NCTC 113351)-IRMM448, 2007 Publications Office of the European Union, LU, EUR 22504 EN, ISBN 92-79-03469-3.
34. ISBER Best Practices for Repositories: Collection, storage, retrieval and distribution of biological materials for research. Third Edition. Biopreserv Biobank 2012;10: 79-161.
35. Betsou F, Luzergues A, Carter A, et al. Towards norms for accreditation of biobanks for human health and medical research: Compilation of existing guidelines into ISO certification/accreditation norm-compatible format. Qual Assur J 2007;11:219-292.